These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26295265)

  • 1. Targeting the Checkpoint to Kill Cancer Cells.
    Benada J; Macurek L
    Biomolecules; 2015 Aug; 5(3):1912-37. PubMed ID: 26295265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATR/CHK1 inhibitors and cancer therapy.
    Qiu Z; Oleinick NL; Zhang J
    Radiother Oncol; 2018 Mar; 126(3):450-464. PubMed ID: 29054375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting nuclear kinases in cancer: development of cell cycle kinase inhibitors.
    Pitts TM; Davis SL; Eckhardt SG; Bradshaw-Pierce EL
    Pharmacol Ther; 2014 May; 142(2):258-69. PubMed ID: 24362082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the S and G2 checkpoint to treat cancer.
    Chen T; Stephens PA; Middleton FK; Curtin NJ
    Drug Discov Today; 2012 Mar; 17(5-6):194-202. PubMed ID: 22192883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathways: Targeting ATR in Cancer Therapy.
    Karnitz LM; Zou L
    Clin Cancer Res; 2015 Nov; 21(21):4780-5. PubMed ID: 26362996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting WEE1 Kinase in Cancer.
    Matheson CJ; Backos DS; Reigan P
    Trends Pharmacol Sci; 2016 Oct; 37(10):872-881. PubMed ID: 27427153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe.
    De Witt Hamer PC; Mir SE; Noske D; Van Noorden CJ; Würdinger T
    Clin Cancer Res; 2011 Jul; 17(13):4200-7. PubMed ID: 21562035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.
    Li S; Wang L; Wang Y; Zhang C; Hong Z; Han Z
    J Hematol Oncol; 2022 Oct; 15(1):147. PubMed ID: 36253861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells.
    Mukhopadhyay UK; Senderowicz AM; Ferbeyre G
    Cancer Res; 2005 Apr; 65(7):2872-81. PubMed ID: 15805289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies.
    Puigvert JC; Sanjiv K; Helleday T
    FEBS J; 2016 Jan; 283(2):232-45. PubMed ID: 26507796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics.
    Ma CX; Janetka JW; Piwnica-Worms H
    Trends Mol Med; 2011 Feb; 17(2):88-96. PubMed ID: 21087899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint control and cancer.
    Medema RH; Macůrek L
    Oncogene; 2012 May; 31(21):2601-13. PubMed ID: 21963855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
    Ashwell S; Zabludoff S
    Clin Cancer Res; 2008 Jul; 14(13):4032-7. PubMed ID: 18593978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase inhibitor coralyne photosensitizes DNA, leading to elicitation of Chk2-dependent S-phase checkpoint and p53-independent apoptosis in cancer cells.
    Patro BS; Maity B; Chattopadhyay S
    Antioxid Redox Signal; 2010 Apr; 12(8):945-60. PubMed ID: 19922265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.
    Wang Y; Li J; Booher RN; Kraker A; Lawrence T; Leopold WR; Sun Y
    Cancer Res; 2001 Nov; 61(22):8211-7. PubMed ID: 11719452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the replication stress response in cancer.
    Forment JV; O'Connor MJ
    Pharmacol Ther; 2018 Aug; 188():155-167. PubMed ID: 29580942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of DNA damage checkpoints in the pathogenesis of human cancers.
    Poehlmann A; Roessner A
    Pathol Res Pract; 2010 Sep; 206(9):591-601. PubMed ID: 20674189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells.
    Wang Y; Liu Q; Liu Z; Li B; Sun Z; Zhou H; Zhang X; Gong Y; Shao C
    Mutat Res; 2012 Jun; 734(1-2):20-9. PubMed ID: 22561209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 activates G₁ checkpoint following DNA damage by doxorubicin during transient mitotic arrest.
    Hyun SY; Jang YJ
    Oncotarget; 2015 Mar; 6(7):4804-15. PubMed ID: 25605022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.